Found: 15
Select item for more details and to access through your institution.
Editorial Board.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, n. 11, p. A4, doi. 10.1016/S2152-2650(19)32055-5
- Publication type:
- Article
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic Malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Use of Patient and Disease Characteristics as Predictive Indicators of Rituximab Infusion-Related Reactions in Adult Malignant Hematology Patients at an Academic Medical Center.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Successful Employment of Brentuximab Vedotin in a Patient Undergoing Hemodialysis: The First Real-life Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term Remission by Brentuximab Vedotin for Non-mediastinal Gray Zone Lymphoma Refractory to Autologous Stem Cell Transplantation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of Different Conditioning Regimens in Allogeneic Hematopoietic Stem-Cell Transplantation Shows Superiority of Total Body Irradiation-Based Regimen for Younger Patients With Acute Leukemia: A Nationwide Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Table of Contents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, n. 11, p. A12,A19, doi. 10.1016/S2152-2650(19)32056-7
- Publication type:
- Article